Richards William G 4
4 · 23andMe Holding Co. · Filed Sep 19, 2023
Insider Transaction Report
Form 4
Richards William G
Head of Therapeutics Discovery
Transactions
- Award
Stock Option (Right to Buy)
2023-09-15+166,394→ 166,394 totalExercise: $1.10Exp: 2033-09-15→ Class A common Stock (166,394 underlying) - Award
Class A common Stock
2023-09-15+344,050→ 555,091 total - Award
Class A common Stock
2023-09-15+115,641→ 670,732 total
Footnotes (3)
- [F1]Grant of restricted stock units (the "RSUs") under the 23andMe Holding Co. Amended and Restated 2021 Incentive Equity Plan (the "Plan"). The RSUs vest equally in 1/12 quarterly installments commencing on February 20, 2024. The vesting of the RSUs is subject to continued service for 23andMe Holding Co. (the "Company"), the terms and conditions of the applicable award agreement, and applicable tax withholding obligations. Each RSU represents the contingent right to receive one share of Class A common stock of the Company.
- [F2]Grant of RSUs under the Company's Plan. The RSUs vest in full on August 20, 2024. The vesting of the RSUs is subject to continued service for the Company, the terms and conditions of the applicable award agreement, and applicable tax withholding obligations. Each RSU represents the contingent right to receive one share of Class A common stock of the Company.
- [F3]Grant of stock options under the Plan. The stock options vest equally in 1/36 monthly installments commencing on October 15, 2023. The vesting of the options is subject to continued service for the Company, the terms and conditions of the applicable award agreement, and applicable tax withholding obligations.